Prognostic Significance of c-ABL Methylation in Chronic Myelogenous Leukemia: Still an Open Question
Open Access
- 1 August 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (3) , 1141-1142
- https://doi.org/10.1182/blood.v94.3.1141.415a35d_1141_1142
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Methylation of the ABL1 Promoter in Chronic Myelogenous Leukemia: Lack of Prognostic SignificanceBlood, 1999
- Antagonistic Effects of ABL and BCRABL Proteins on Proliferation and the Response to Genotoxic Stress in Normal and Leukemic Myeloid CellsLeukemia & Lymphoma, 1998
- Molecular Follow-Up of Disease Progression and Interferon Therapy in Chronic Myelocytic LeukemiaBlood, 1997
- Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.Proceedings of the National Academy of Sciences, 1994